FDA approved a premarket approval supplement application for Novocure’s second generation Optune system. The Tumor Treating Fields delivery system is now available to glioblastoma patients in the U.S. The new model features a generator that is less than half the weight and half the size of the generator in the first generation system. Additional improvements... […]
FDA granted Orphan Drug Designation to TK216 for the treatment of Ewing sarcoma. Oncternal Therapeutics Inc., the drug’s sponsor, is in the process of initiating a first-in-human phase I trial of TK216 in relapsed or refractory Ewing sarcoma. The company recently received Fast Track Designation in this indication. TK216 is a first-in-class small molecule that... […]
FDA granted a Rare Pediatric Disease Designation to ABT-414, an investigational antibody drug conjugate targeting the epidermal growth factor receptor for the treatment of pediatric patients with EGFR-amplified Diffuse Intrinsic Pontine Glioma, known to be highly aggressive and difficult to treat brain tumors found at the base of the brain. According to AbbVie, the drug’s... […]
Health Canada approved Tagrisso (osimertinib) for patients with locally advanced or metastatic EGFR T790M mutation-positive non-small cell lung cancer who have progressed on or after EGFR tyrosine kinase inhibitor therapy. Tagrisso, sponsored by AstraZeneca Canada, was granted Notice of Compliance with Conditions, based on promising evidence of clinical efficacy data, pending the results of additional... […]
FDA approved performing the Roche cobas HPV Test from cervical specimens collected in BD SurePath Preservative Fluid using the BD SurePath vial.
USC NORRIS Comprehensive Cancer Center entered into a collaboration agreement with Trovagene Inc. to establish a standardized framework for the use of Trovera urine liquid biopsy testing at USC as well as to define practical considerations and best practices for liquid biopsy testing from urine. The collaboration will also explore the development of clinical treatment... […]
THE BONNIE J. ADDARIO Lung Cancer Foundation and the Van Auken Private Foundation announced the recipients of the second annual ALCF-VAPF Young Innovators Team Award. The two organizations awarded $500,000 to a team of researchers exploring the causes of chemotherapy resistant small-cell lung cancer and identifying new inhibitors. The winning proposal, by David MacPherson, of... […]
THE AMERICAN SOCIETY FOR RADIATION ONCOLOGY elected five new officers to the society’s board of directors, including president-elect, secretary-treasurer-elect, and vice-chairs of three of ASTRO’s five councils: Clinical Affairs and Quality, Education, and Government Relations. Terms for all positions begin at ASTRO’s annual meeting, Sept. 25-28 in Boston. The new board members are: President-Elect Paul... […]
REGENERON PHARMACEUTICALS Inc. announced three of the winners of the fourth annual Regeneron Prize for Creative Innovation, an award designed to acknowledge, reward and foster talented early-career biomedical scientists. Altogether, Regeneron will award $155,000 in prize money to 10 awardees and two institutions. Two winners of the Regeneron Prize will each receive a $50,000 cash... […]
MICHELE RUSSELL-EINHORN will join Schulman IRB as vice president for oncology services, effective Sept. 1. Russell-Einhorn will build and lead Schulman’s Central Oncology Review division, to be launched later this year. As senior director of Dana-Farber Cancer Institute’s Office for Human Research Studies, Russell-Einhorn managed and oversaw five scientific review committees and seven institutional review... […]
